From earnings to developments in China to the latest COVID news, Jim Cramer put his schedule for the next week on during Friday’s Mad Money show.
On Monday, Cramer said he would be checking for the latest updates on China’s Evergrande group, as well as who the next “enemy” of China might be. The country is going through tough times and that makes it difficult for investors and companies.
On Tuesday we receive income from Micron (MU) – Get the report from Micron Technology, Inc. (MU). Let’s see how the company fares, suggested Cramer, while saying he would buy dips from Advanced Micro Devices (AMD) – Get the report from Advanced Micro Devices, Inc. and Nvidia (NVDA) – Get the NVIDIA Corporation report when hit in Micron’s neighborhood. Thor Industries (NS) – Get Thor Industries, Inc. report will also report the receipts.
On Real Money, Jim Cramer writes that if analysts got more real-life experience, they could help people make a lot more money. Instead, they just focus on the wrong things. Read more about what he says about earnings, analysts, and their reactions to Nike, Costco, and Salesforce.
Investors should get a good idea of how small and medium-sized businesses are doing when Cintas (CTAS) – Get the Cintas Corporation report and Herman Miller (MLHR) – Get the Herman Miller, Inc. report announce their quarterly results on Wednesday.
Thursday will be busy with Bed Bath & Beyond (BBBY) – Get the report from Bed Bath & Beyond Inc. Reporting, together with CarMax (KMX) – Get CarMax, Inc. Report. Paychex (PAYX) – Get the Paychex, Inc. report will also report profits and Cramer is happy to buy the dip on that behalf. McCormick (MKC) – Get McCormick & Company, Incorporated (MKC) report will report too, and while it’s a great company, Cramer suggested avoiding that name for now.
On Friday, Cramer would like to take a look at the latest COVID-19 data to see which way the case numbers are headed.
Here’s the bottom line: get ready, said Cramer, because after next week we’ll get the monthly job report and the earnings season will go into effect. Next week is like the “calm before the storm,” he added.
Executive Decision: Good Rx
In our complicated world of healthcare, GoodRx is just trying to help Americans understand all of the information, Hirsch said.
It takes the average consumer several weeks to get in touch with the doctor, while GoodRx can provide simple answers and videos to help relieve that stress.
The stock has risen since GoodRx was last featured on Monday Money in July (about 14% over the past three months). Cramer said he continues to like it and isn’t worried about potential competition.
Browse Jim Cramer’s “Mad Money” trading recommendations with our exclusive “Mad Money” stock screener.
To sign up for Jim Cramer’s free Booyah! Newsletter with all of his latest articles and videos Please click here.
At the time of publication, Action Alerts PLUS had no position in the stocks mentioned.